Evidence map›Paper›PMID 41149747›Full record

ArticleJournal of xenobiotics2025

The Antiproliferative Activity of Tatridin A Against Prostate Cancer Cells Is Lost in Acid Medium by Transformation to Desacetyl-β-Cyclopyrethrosin.

Cecilia Villegas, Rebeca Pérez, Camilo Céspedes-Méndez, Viviana Burgos, Ricardo Baggio, Sebastián Suárez, Bernd Schmidt, Cristian Paz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of xenobiotics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cecilia VillegasDepartment of Biological and Chemical Sciences, Faculty of Natural Resources, Catholic University of Temuco, Rudecindo Ortega 02950, Temuco 4780000, Chile.ORCID 0000-0002-9066-1763
Rebeca PérezPharmaceutical Chemistry Program, Faculty of Health Sciences, Autonomous University of Chile, Avenida Alemania 01090, Temuco 4780000, Chile.
Camilo Céspedes-MéndezPharmaceutical Chemistry Program, Faculty of Health Sciences, Autonomous University of Chile, Avenida Alemania 01090, Temuco 4780000, Chile.
Viviana BurgosFaculty of Health, School of Medical Technology, Santo Tomás University, Temuco 4780000, Chile.
Ricardo BaggioResearch and Applications Management, Constituyentes Atomic Center, National Atomic Energy Commission, San Martín, Buenos Aires B1650LWP, Argentina.
Sebastián SuárezDepartment of Analytical Chemistry and Instrumental Analysis, Faculty of Sciences, Francisco Tomás y Valiente St. No. 7, Campus of Excellence, Autonomous University of Madrid, 28049 Madrid, Spain.ORCID 0000-0003-0236-5743
Bernd SchmidtInstitute of Chemistry, University of Potsdam, Karl-Liebknecht-Straße 24-25, D-14476 Potsdam, Germany.ORCID 0000-0002-0224-6069
Cristian PazLaboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, University of La Frontera, Temuco 4780000, Chile.ORCID 0000-0002-4668-4984

Funding

Agencia Nacional de Investigación y Desarrollo 1220831
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

eudesmanolidegermacranolideNF-κB inhibitionprostate cancersesquiterpene lactonestatridin A

Identifiers

PMID41149747
PMCPMC12565412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.